IP Library Granted Patent US 8,841,433
Granted Patent B2
US 8,841,433 · App. 12/284,347 · Granted Sep 23, 2014

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Inventors: Ronaldus Adrianus Maria Fouchier (Rotterdam, NL); Bernadetta Gerarda Van Den Hoogen (Rotterdam, NL); Albertus Dominicus Marcellinus Erasmus Osterhaus (Antwerp, BE); Jan Cornelius De Jong (Gouda, NL); Jan Groen (Laguna Niguel, CA)
Assignee: ViroNovative BV
G01N33/5011A61K2039/5256G01N33/502C07K14/005C12N2760/18334C12N15/86G01N33/5008C12N7/00C12N2760/18522C12N2760/18634C12N2760/18534A61K2039/5254C12N2760/18643C12N2760/18343C12N2840/203C12N2760/18621A61K39/155G01N33/56983C12N2760/18622C07K16/1027C12N2760/18322G01N33/5088A61K2123/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,841,433
App. No.
12/284,347
Granted
Sep 23, 2014
Kind
B2
Abstract

Provided is an isolated mammalian negative strand RNA virus, metapneumovirus (MPV), within the sub-family Pneumoviridae, of the family Paramyxoviridae. Also provided are isolated mammalian negative strand RNA viruses identifiable as phylogenetically corresponding or relating to the genus Metapneumovirus and components thereof. In particular, provided is a mammalian MPV, subgroups and variants thereof. Also provided are genomic nucleotide sequences of different isolates of mammalian MPV, in particular, human MPV. Disclosed is the use of the sequence information of different isolates of mammalian MPV for diagnostic and therapeutic methods. Provided are nucleotide sequences encoding the genome of a MPV or a portion thereof, including both mammalian and avian MPV. Further described are chimeric or recombinant viruses encoded by the nucleotide sequences, and chimeric and recombinant mammalian MPV that comprise one or more non-native or heterologous sequences. Also provided are vaccine formulations comprising mammalian or avian MPV, including recombinant and chimeric forms thereof. The vaccine preparations encompass multivalent vaccines, including bivalent and trivalent vaccine preparations.

Claims (1)

1. An isolated DNA, wherein the DNA has a nucleotide sequence that is at least 95% identical to SEQ ID NO:20, wherein sequence identity is determined over the entire length of SEQ ID NO:20.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2016
From: VIRONOVATIVE B.V.
To: ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
Reel/Frame 037726/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2015
From: MEDIMMUNE LLC; MEDIMMUNE VACCINES, INC.
To: VIRONOVATIVE, BV
Reel/Frame 035269/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2015
From: FOUCHIER, RONALDUS ADRIANUS MARIA; VAN DEN HOOGEN, BERNADETTA GERARDA; OSTERHAUS, ALBERTUS DOMINICUS MARCELLINUS ERASMUS; DE JONG, JAN CORNELIUS; GROEN, JAN
To: VIRONOVATIVE BV
Reel/Frame 035055/0745 →
Continuity (3)
Continuation 10371099 · Feb 21, 2003
Provisional Application 60358934 · Feb 21, 2002
Related Publication 20090246855A1 · Oct 1, 2009